Breaking News
Sort by:
Top Post
Memorial MRI & Diagnostic Installs United Imaging's Pioneering 75 Cm, Ultra-wide-bore uMR OMEGA™
United Imaging, a global leader in manufacturing advanced medical imaging and radiotherapy equipment, and Memorial […]
Global Access Diagnostics (GADx) Formed to Expand Affordable Access to Advanced Rapid Diagnostic Technologies
Global Access Health (GAH), a social enterprise dedicated to providing affordable medical products for global […]
Remington Announces Launch of VascuChek®, A Wireless, Vascular Doppler Device
Remington Medical, a medical device manufacturing company based in the U.S., announced the launch of […]
MEDICALGORITHMICS Secured FDA Approval for Qpatch Wearable
Qpatch is a state-of-the-art wearable device for measuring individual ECG signal to obtain accurate cardiac […]
Bio-Rad Launches SEQuoia Express Stranded RNA Library Prep Kit at AGBT 2022
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and […]
Abbott Announces Development of Novel Continuous Glucose-Ketone Monitoring System
Abbott (NYSE: ABT) today announced it’s developing a new biowearable that will continuously monitor glucose and […]
Medtronic and DaVita Announce New Kidney Health Technology Company
Medtronic plc (NYSE:MDT) and DaVita Inc. (NYSE:DVA) today announced the intent to form a new, independent kidney care-focused […]
Bio-Rad Launches CFX Duet Real-Time PCR System
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and […]
NuvoAir Launches Remote Asthma Service to Support NHS with Faster Diagnosis and Treatment
NuvoAir’s Asthma Assessment Service uses respiratory physiologists and connected, award-winning home monitoring technology, such as […]
Leia Inc. Partners With Anatomage to Enable 3D Stereoscopic Learning Through Anatomage VR
Leia Inc., the leading 3D experience platform leveraging proprietary Nanotechnology and AI to democratize the […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more